Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
- PMID: 32338741
- PMCID: PMC7279514
- DOI: 10.1093/eurheartj/ehaa357
Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
Comment on
-
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190. Eur Heart J. 2021. PMID: 32176300 Free PMC article. No abstract available.
References
-
- Kishimoto C, Shioji K, Hashimoto T, Nonogi H, Lee JD, Kato S, Hiramitsu S, Morimoto SI. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels 2014,29:336–342. - PubMed
-
- Pankuweit S, Maisch B. [ Etiology, diagnosis, management, and treatment of myocarditis: position paper from the ESC Working Group on Myocardial and Pericardial Diseases]. Herz 2013;38:855–861. - PubMed
-
- Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 2020;141:e69–e92. - PubMed
